Knowledge Center

Article / Jun 08, 2009

A Well-Integrated Sideline. Deal to supply an inhaler device to Daiichi Sankyo marks a big victory for ËÄÉ«AV

Authors:
Source:
C&EN, 8 June, 2009

Spirits were high as Portugal-based executives from ËÄÉ«AV arrived in Cork, Ireland, in late April for the inauguration of the company's newly acquired pharmaceutical chemical facility. The acquisition, from Pfizer, closed on April 8, the same day as the company's 50th anniversary.

Related links

Also in the Knowledge Center

Related Content

Formulation

We develop inhalation & nasal products with our partners following Quality by Design principles to reach optimal product performance through robust processes.

Page
Read more

Financial Stability

ËÄÉ«AV is a well established and financially stable company

Page
Read more

Drug delivery platforms

ËÄÉ«AV has unique capabilities and expertise in solubility enhancement, lung delivery, modified release and taste-masking applications.

Page
Read more